Clinical Trial Update: A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating levetiracetam as monotherapy or adjunctive therapy for partial seizures in children aged 1 month to less than 4 years; results posted J…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial Seizures

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: UCB Japan Co. Ltd. | Conditions: Partial Seizures | Phase 3 | Status: COMPLETED | Results posted: 2024-07-23